MENU

VYNE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

VYNE Therapeutics (VYNE) Ownership - Who owns VYNE Therapeutics?

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Pharmaceuticals Major

Address

685 Route 202/206 North

Phone

+1 800 775-7936

Employees

10

Web

https://www.vynetherapeutics.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

21.7M

P/E Ratio

0.71

Total Cash

24.93M

Projected Growth

N/A

Total Debt

N/A

Revenue

454K

Risk (Beta)

0.80

Dividend Yield

N/A

Total Cash/Share

0.75

Total Debt/Equity

N/A

Revenue/Share

0.01 USD as % of share price

View a ticker or compare two or three

VS

VS

VYNE

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for VYNE

A.I. Advisor

published General Information

General Information

a company, which engages in development and commercialization of serlopitant products

Industry Biotechnology

Profile

Details

Industry

Pharmaceuticals Major

Address

685 Route 202/206 North

Phone

+1 800 775-7936

Employees

10

Web

https://www.vynetherapeutics.com